Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Over the past 3 months, 4 analysts have published their opinion on Newmark Group (NASDAQ:NMRK) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

What 4 Analyst Ratings Have To Say About The Middleby

Within the last quarter, The Middleby (NASDAQ:MIDD) has observed the following analyst ratings:

Benzinga

Tenon Medical, Inc To Start Trading Tomorrow

Tenon Medical, Inc (NASDAQ:TNON) IPO will take place April, 27 on the NASDAQ exchange under the ticker TNON. The company is offering shares at an expected price between $4.50 and $5.50 per share with an insider lock-up period of 180 days ending on October 24, 2022.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Preview: Innovative Eyewear, Inc. Set To IPO Tomorrow

Innovative Eyewear, Inc. (NASDAQ:LUCY) IPO will take place April, 27 on the NASDAQ exchange under the ticker LUCY. The company is offering shares at an expected price between $5.50 and $7.50 per share with an insider lock-up period of 180 days ending on October 24, 2022.

Benzinga

Looking Into Global Blood Therapeutics's Return On Capital Employed

Global Blood Therapeutics (NASDAQ:GBT) brought in sales totaling $56.10 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 23.37%, resulting in a loss of $87.58 million.

Benzinga

Heidrick & Struggles Intl Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Heidrick & Struggles Intl (NASDAQ:HSII) earned $18.47 million, a 48.01% increase from the preceding quarter. Heidrick & Struggles Intl's sales decreased to $283.86 million, a 0.59% change since Q4.

Benzinga

Dorman Products's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, Dorman Products (NASDAQ:DORM) earned $35.21 million, a 3.31% increase from the preceding quarter. Dorman Products also posted a total of $401.58 million in sales, a 0.85% increase since Q4.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap: Bank7 Q1 Earnings

Bank7 (NASDAQ:BSVN) reported its Q1 earnings results on Tuesday, April 26, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Benzinga

Looking Into Cadence Design Systems's Return On Capital Employed

According to Benzinga Pro, during Q1, Cadence Design Systems (NASDAQ:CDNS) earned $235.34 million, a 33.27% increase from the preceding quarter. Cadence Design Systems also posted a total of $901.77 million in sales, a 16.65% increase since Q4.

Benzinga

Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease

Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate PRX012 for the treatment of Alzheimer's disease.

Benzinga

Benzinga's Daily Brief On Trending Tickers For April 26, 2022: Raytheon, GE, Warner Bros., Digital World Acquisition And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Benzinga

India Tries To Attract Intel, TSMC, GlobalFoundries To Set Up Local Plant

India is in talks with global chipmakers Intel Corp (NASDAQ:INTC), GlobalFoundries Inc (NASDAQ:GFS), and Taiwan Semiconductor Manufacturing Co Ltd (NYSE:TSM) about setting up local operations, Bloomberg reports. India aspires to become an electronic hub like neighbor China, Bloomberg notes. In India, a venture between billionaire Anil Agarwal’s Vedanta Group and Apple Inc (NASDAQ:AAPL) supplier Hon Hai Precision Industry Co Ltd (OTC:HNHPF),…

Benzinga

Gamida Cell Shares Jump On FDA Nod To Cell Therapy Trial In Blood Cancer Settings

The FDA has signed off and removed the clinical hold for a cryopreserved formulation of Gamida Cell Ltd's (NASDAQ:GMDA) GDA-201, an off-the-shelf cell therapy candidate for follicular and diffuse large B cell lymphomas. Gamida Cell expects to initiate a Phase 1/2 clinical study in patients with follicular and diffuse large B-cell lymphomas in 2022.…

Benzinga

U.S. FDA Grants Fast Track designation To Ofra-Vec (VB-111) For Platinum-Resistant Ovarian Cancer

VBL Therapeutics (NASDAQ: VBLT) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Ofra-Vec (VB-111) in combination with Paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Expert Ratings for Nkarta

Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter:

Benzinga

Looking Into AMAZON.COM Inc's Recent Short Interest

AMAZON.COM Inc's (NASDAQ:AMZN) short percent of float has fallen 13.54% since its last report. The company recently reported that it has 3.65 million shares sold short, which is 0.83% of all regular shares that are available for trading.

Benzinga

Analyst Ratings for Zillow Gr

Zillow Gr (NASDAQ:ZG) has observed the following analyst ratings within the last quarter:

Benzinga

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Old National Bancorp: Q1 Earnings Insights

Old National Bancorp (NASDAQ:ONB) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

United Bankshares: Q1 Earnings Insights

United Bankshares (NASDAQ:UBSI) reported its Q1 earnings results on Tuesday, April 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings United Bankshares reported in-line EPS of $0.6 versus an estimate of $0.6.

Benzinga

Arrow Financial: Q1 Earnings Insights

Arrow Financial (NASDAQ:AROW) reported its Q1 earnings results on Tuesday, April 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

LCNB: Q1 Earnings Insights

LCNB (NASDAQ:LCNB) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Carter Bankshares: Q1 Earnings Insights

Carter Bankshares (NASDAQ:CARE) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

What 5 Analyst Ratings Have To Say About Werner Enterprises

Over the past 3 months, 5 analysts have published their opinion on Werner Enterprises (NASDAQ:WERN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Where Hub Group Stands With Analysts

Within the last quarter, Hub Group (NASDAQ:HUBG) has observed the following analyst ratings:

1 … 579 580 581 582

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Cadence Design Systems

80 stories

Nektar

32 stories

Taiwan Semiconductor Manufacturing Co Ltd

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.